-
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trialLopes RD, Vora AN, Liaw D et al. -
TACIT (High Sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial): An Observational Study to Identify Acute Heart Failure Patients at Low Risk for Rehospitalization or MortalityPang PS, Fermann GJ, Hunter BR et al.
-
Prevalence of Angina Among Primary Care Patients With Coronary Artery DiseaseDM Blumenthal, SE Howard, JS Como et al.
-
Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic ShockA Lemor, MB Basir, and on behalf of the National Cardiogenic Shock Initiative Investigators.
-
Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-studyNaber CK, Urban P, LEADERS FREE Investigators et al.
-
Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL TrialR Moxham, V Džavík; J Cairns et al.
-
Percutaneous Support Devices for Percutaneous Coronary InterventionPatel MR.
-
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art ReviewEB Wu , ES Brilakis, K Mashayekhi et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
